Evidence map›Paper›PMID 29465801›Full record

ArticleChembiochem : a European journal of chemical biology2018

Near-Infrared Light-Controlled Gene Expression and Protein Targeting in Neurons and Non-neuronal Cells.

Taras A Redchuk, Maksim M Karasev, Evgeniya S Omelina, Vladislav V Verkhusha

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Toward Multiplexed Optogenetic Circuits.Frontiers in bioengineering and biotechnology · 2021
    Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Taras A RedchukMedicum, Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland.ORCID 0000-0002-6724-9025
Maksim M KarasevMedicum, Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland.ORCID 0000-0002-3966-7908
Evgeniya S OmelinaMedicum, Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland.ORCID 0000-0002-2189-5101
Vladislav V VerkhushaMedicum, Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland.ORCID 0000-0002-2083-8121
University of Helsinki · FIAlbert Einstein College of Medicine · US

Funding

Near-Infrared Fluorescent Proteins, Biosensors and Optogenetic ToolsR35GM122567 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vladislav Verkhusha · 2017 to 2026
$4.3M
Calcium biosensors for deep-tissue imaging and spectral multiplexingU01NS103573 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI VERKHUSHA, VLADISLAV · 2017 to 2019
$1.8M
NIGMS NIH HHS R35 GM122567NINDS NIH HHS U01 NS103573
6 · The paper itself

Abstract

Near-infrared (NIR) light-inducible binding of bacterial phytochrome BphP1 to its engineered partner, QPAS1, is used for optical protein regulation in mammalian cells. However, there are no data on the application of the BphP1-QPAS1 pair in cells derived from various mammalian tissues. Here, we tested the functionality of two BphP1-QPAS1-based optogenetic tools-an NIR- and blue-light-sensing system for control of protein localization (iRIS) and an NIR light-sensing system for transcription activation (TA)-in several cell types, including cortical neurons. We found that the performance of these optogenetic tools often relied on physiological properties of a specific cell type, such as nuclear transport, which could limit the applicability of the blue-light-sensitive component of iRIS. In contrast, the NIR-light-sensing component of iRIS performed well in all tested cell types. The TA system showed the best performance in cervical cancer (HeLa), bone cancer (U-2 OS), and human embryonic kidney (HEK-293) cells. The small size of the QPAS1 component allowed the design of adeno-associated virus (AAV) particles, which were applied to deliver the TA system to neurons.

Indexed as

AnimalsBacterial ProteinsCell LineCells, CulturedChlorocebus aethiopsCOS CellsGene ExpressionHEK293 CellsHeLa CellsHumansInfrared RaysLightLuminescent ProteinsMiceNeuronsOptogeneticsBacterial ProteinsLuminescent ProteinsPhytochromeProteinsRed Fluorescent ProteinBphP1gene expressionnear-infraredoptogeneticQPAS1

Identifiers

PMID29465801
PMCPMC6317872
OpenAlexW2789851030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.